AG0070FI

475108-18-0 | Tivozanib

Chemical structure of Tivozanib, CAS 475108-18-0
AG0070FI
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 475108-18-0
Catalog Number AG0070FI(AGN-PC-0JEKOV)
Chemical Name Tivozanib
IUPAC Name 1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea
InChI InChI=1S/C22H19ClN4O5/c1-12-8-21(27-32-12)26-22(28)25-16-5-4-13(9-15(16)23)31-18-6-7-24-17-11-20(30-3)19(29-2)10-14(17)18/h4-11H,1-3H3,(H2,25,26,27,28)
InChI Key SPMVMDHWKHCIDT-UHFFFAOYSA-N
MDL Number MFCD15146788
Molecular Formula C22H19ClN4O5
Molecular Weight 454.8631
SMILES O=C(NC1=NOC(C)=C1)NC2=CC=C(OC3=CC=NC4=CC(OC)=C(OC)C=C34)C=C2Cl
UNII 172030934T
Synonyms
AV 951, AV-951, AV951 cpd, KRN 951, KRN-951, KRN951, tivozanib, Tivozanib, 475108-18-0, AV-951, Tivozanib (AV-951), KRN-951, AV 951, AV951, KRN951, KRN 951, N-[2-CHLORO-4-[(6,7-DIMETHOXY-4-QUINOLYL)OXY]PHENYL]-N'-(5-METHYL-3-ISOXAZOLYL)UREA, UNII-172030934T, CHEMBL1289494, 1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea, 1-(2-CHLORO-4-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PHENYL)-3-(5-METHYLISOXAZOL-3-YL)UREA, AV-951(Tivozanib), J-502964, 172030934T, fotivda, Kil-8951, Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor IV, 1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea, N-(2-Chloro-4-((6,7-dimethoxy-4-quinolyl)oxy)phenyl)-N′-(5-methyl-3-isoxazolyl)urea, N-(2-Chloro-4-((6,7-dimethoxy-4-quinolyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)urea, ASP-4130, Tivozanib [USAN:INN], 4ase, KIL8951, N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea, AV-951,Tivozanib, PubChem22421, Tivozanib(AV-951), Tivozanib (USAN/INN), Tivozanib - AV-951, MLS006011287, SCHEMBL172883, GTPL6058, CHEBI:91327, KS-00001CTN, EX-A472, SYN1013, SPMVMDHWKHCIDT-UHFFFAOYSA-N, HMS3229O09, HMS3244C19, HMS3244C20, HMS3244D19, HMS3265A11, HMS3265A12, HMS3265B11, HMS3265B12, HMS3654G22, AOB87139, BCP01980, ZINC1489430, ABP001003, AN-470, BDBM50331095, MFCD15146788, RS0093, s1207, AKOS022177607, AV951 (KRN951, TIVOZANIB), BCP9000343, CCG-206805, CS-0103, DB11800, EX-8600, KIN0000444, KRN 951 /TIVOZANIB/AV-951, PB28569, NCGC00249390-01, NCGC00249390-05, 4CA-1259, AC-24702, AJ-26332, AK-41796, AS-16997, BC659936, HY-10977, SC-54549, SMR004703037, AB0007909, FT-0700315, ST24037076, SW219364-1, X4932, A24970, D09683, Q-3811, 108K180, BRD-K53414658-001-01-7, N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]pheny, AV951, AV-951, 475108-18-0, 1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)-oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea, 1-[2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-3-(5-methylisoxazol-3-yl)urea, 1-{2-chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-3-(5-methyl-1,2-oxazol-3-yl)urea, N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea, Urea, N-(2-chloro-4-((6,7-dimethoxy-4-quinolinyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)-, 1-(2-chloro-4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-3-(5-methylisoxazol-3-yl)urea;AV-951, 1-{2-chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-3-[(3E)-5-methylisoxazol-3(2H)-ylidene]urea, AV9, AV951 Tivozanib, Tivozanib [USAN], cc-12, D0W7JZ, C22H19ClN4O5, Tivozanib hydrochloride monohydrate, ASP4130/AV-951, VEGFR Tyrosine Kinase Inhibitor IV, ACN-041317, CID9911830, A2251, A10101, 1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxy-phenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited